Patent · US Active

Articles of manufacture and methods for treatment using adoptive cell therapy

US11413310B2 · kind B2 · utility

10Cited by
93References
55Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2018
Grant dateAug 16, 2022
Priority date
Expiry dateJan 10, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2239/38
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are adoptive cell therapy methods involving the administration of doses of cells for treating disease and conditions, including certain B cell malignancies. The cells generally express recombinant receptors such as chimeric antigen receptors (CARs). In some embodiments, the methods are for treating subjects with non-Hodgkin lymphoma (NHL). In some embodiments, the methods are for treating subjects with relapsed or refractory NHL. Also provided are articles of manufacture and prophylactic treatments in connection with adoptive therapy methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.